11th International Conference on Cachexia, Sarcopenia & Muscle Wasting

Friday 7 December 2018
10.00-11.30 A Clinical and societal impact of cachexia & sarcopenia
Recent facts & figures Stephan von Haehling Germany
Clinicians quest: Geriatrician Francesco Landi Italy
Clinicians quest: Medical oncologist Florian Strasser Switzerland
Clinicians quest: Surgeon Steven Olde Damink The Netherlands
Patients quest TBD
11.30-12.00 Appetizer: Highlights of afternoon workshops Workshops chairs
12.00-13.00 Lunch
13.00-17.00 B Workshops: Innovation & implementation
18.00-20.00 Welcome reception
Saturday 8 December 2018
7.15-8.15 Ken Fearon Career Café – Meet the mentors (statistical seminar)
8.30-10.00 D Plenary: Multilayered triggers of chronic disease associated wasting
Acute events upon chronic wasting in COPD
Clinical perspective TBD
Basic research insights Ramon Langen The Netherlands
Striated muscle pathology in cardiac cachexia
Clinical perspective TBD
Basic research insights TBD
Chronic kidney disease + accelerated aging
Clinical perspective Kamyar Kalantar-Zadeh USA
Basic research insights Xiaonan H. Wang USA
10.00-11.00 Break + Poster session
11.00-12.30 E Basic track: Tumor secreted triggers of cachexia
Stephan Herzig Germany
Tumor-derived Hsp-70/90 in cancer cachexia Yi-Ping Li USA
Transfer of enzymatic activity of Tumor-borne extracellular vesicles Mauricio Berriel Diaz Germany
Tumor gp130 ligands expression and release in cancer cachexia Teresa Zimmers USA
F Clinical track: Emerging fields in critical illness wasting
Muscle metabolism and physiology in chronic critical illness Zudin Puthucheary UK
TBD David Griffith UK
Persistent inflammation immunosuppression catabolic syndrome Scott Brakenridge USA
12.30-13.30 Lunch Break + Seminar
13.30-15.00 G Basic track: Non-tumor derived factors involved in muscle wasting
Inflammatory and glucocorticoid signaling in muscle atrophy Rowan Hardy UK
Inflammation and control of muscle mass James Carson USA
Muscle-derived growth factors and muscle atrophy Vanina Romanello Italy
H Clinical track: Challenges of cancer induced wasting in the older patient
Update on treatment options for cancer cachexia Maurizio Muscaritoli Italy
When cancer cachexia occurs with sarcopenia  Aminah Jatoi USA
  Clinical presentations and outcomes
Controversies of comprehensive geriatric assessment in weight losing cancer patients TBD
Complex decision making in the older, weight-losing cancer patient Alessandro Laviano Italy
15.00-16.00 Break + Poster session
16.00-17.30 I Basic track: Experimental models
In vitro muscle culture: Muscling in on the third dimension TBD
Mouse avatars in cancer cachexia Andrew Judge USA
Natural (large animal) models of sarcopenia and cachexia Lisa Freeman USA
J Clinical track: Management guidelines for sarcopenia
Rapid screening for sarcopenia John Morley USA
How to pragmatically and meaningfully screen on sarcopenia and physical frailty in community dwelling older people?                                                                    Jos Schols The Netherlands
Targeting muscle quality Bertrand Fougere France
Guidelines for management of sarcopenia Jürgen Bauer Germany
17.30-18.30 K Plenary session: Novel nutritional and pharmacological targets in cachexia and sarcopenia Chairs
Samuel Breit Australia
Epigenetic targeting of bromodomain protein BRD4 Giuseppina Caretti Italy
FGF-19 modulates skeletal muscle mass and wasting TBD
GDF11/15 in skeletal muscle wasting David Glass USA
Multiorgan nutritional targets Josep Argiles Spain
19.30 Anti-cachexia dinner
Sunday 9 December 2018
8.30-10.00 L Plenary session: Multilayered triggers of cancer cachexia Chairs
Andrea Bonetto USA
Tumor-induced local tissue dysfunction contributing to cachexia
Dysphagia in sarcopenia and head and neck cancer Hidetaka Wakabayashi Japan
Cancer associated fibroblasts in pancreatic cancer TBD
Tumor-host interactions in cachexia
Exercise-dependent regulation of tumour microenvironment TBD
Tumor-induced immune- and metabolic reprogramming Thomas Flint UK
Tumor treatment-induced muscle wasting
Influence of the gut microbiota  on anticancer immunosurveillance Areille Elkrief France 
Mechanisms of chemotherapy-induced muscle wasting Riikka Kivelä Finland
10.00-11.00 Break + Poster session
11.00-12.30 M Basic track : Intracellular mechanisms of muscle wasting
Altered muscle proteostasis in muscle wasting Marco Sandri Italy
Role of microRNAs in muscle wasting Paola Costelli Italy
Muscle progenitor cell function and muscle wasting Denis Guttridge USA
N Translational track:  Anabolic resistance in sarcopenia and cachexia: Myth or opportunity?
Sarcopenic obesity Yves Boirie France
Physical inactivity accelerates sarcopenia and leads to metabolic dysfunction Luc van Loon The Netherlands
Exercise as therapeutic approach in cancer cachexia Fabio Penna Italy
* or focus on ageing and chronic disease?
12.30-13.30 Lunch Break + Seminar
13.30-14.30 O Omics approaches in cachexia & sarcopenia research Chairs
Alexander Ebhardt Switzerland
Extra-cellular vesicles in tissue crosstalk during exercise Martin Whitham Australia
Multi-omics analysis of serum reveals tissue crosstalk in cancer Christopher Gerner Austria
Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle Swarnali Acharyya USA
Small RNAome profiling of skeletal muscle in cancer cachexia Sambasivarao Damaraju Canada
P Plenary session: Novel intervention strategies and clinical study designs
Proteomics and sarcopenia/frailty Luigi Ferrucci USA
Evidence versus practice based medicine Stefan Anker Germany
Nutrition & pharma joining forces Annemie Schols The Netherlands
P4 medicine in cachexia & sarcopenia John Morley USA
14.30-16.00 Q Highlights Session     
Treatment TBD
Imaging TBD
Biormarker/sarcopenia TBD
Basic TBD



During the congress an ‘physical activity’ is stimulated by walking & cycling to different locations at the Campus and to the nearby City Centre Awards Ceremony
Best Poster Award 
Young Investigators Award 
Trainee Poster Award